Findings from the BEST3 Trial

Professors Rebecca Fitzgerald and Peter Sasieni discuss how the Cytosponge came to be, the headline findings from the BEST3 Trial and the implications for oesophageal cancer screening.

Dr Nick Swart presents health economics analysis.
Click here to view

Patient perspectives of the Cytosponge

BEST3 participant Liz Chipchase discusses her experience of the Cytosponge and the BEST3 Trial with GP Dr Thomas Round.

Click here to view

Pathology and Artificial Intelligence in BEST3

Join Drs Maria O'Donovan, Marnix Jansen and Marcel Gehrung for an exploration of the pathology of BEST3 and diagnostic artificial intelligence.

Click here to view

The GP perspective: what do the BEST3 trial results mean for GPs and other primary care staff?

Join Drs Fiona Walter and Richard Roope for an exploration of how the BEST3 Trial is the first step towards how the Cytosponge could be implemented in primary care, as well as discussion about how the doctors and nurses involved in the trial feel about the test.

Click here to view

Upcoming Sessions:

The research nurse perspective: insights into coordinating a complex trial and training research and practice nurses to administer the Cytosponge procedure.
With Irene Debiram-Beecham, Siobhan Campbell, Marie Corcoran, Jill Ducker, Lydia Owen and Nicky Todd.

The COVID-19 emergency pathway: how the Cytosponge was used as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic.
With Dr Massimiliano di Pietro, Professor Colin Rees and Professor Laurence Lovat

Don't miss a session

Sign up for emails and be the first to know when events go live!